173 related articles for article (PubMed ID: 38672078)
1. Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression.
Thepthanee C; Ei ZZ; Benjakul S; Zou H; Petsri K; Innets B; Chanvorachote P
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672078
[TBL] [Abstract][Full Text] [Related]
2. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
[TBL] [Abstract][Full Text] [Related]
3. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
Phiboonchaiyanan PP; Chanvorachote P
Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
[TBL] [Abstract][Full Text] [Related]
5. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
Petpiroon N; Sritularak B; Chanvorachote P
BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation.
Phiboonchaiyanan PP; Puthongking P; Chawjarean V; Harikarnpakdee S; Sukprasansap M; Chanvorachote P; Priprem A; Govitrapong P
Clin Exp Pharmacol Physiol; 2021 Dec; 48(12):1712-1723. PubMed ID: 34396568
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits CD133
Acikgoz E; Tatar C; Oktem G
J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
[TBL] [Abstract][Full Text] [Related]
8. Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway.
Thongsom S; Racha S; Petsri K; Ei ZZ; Visuttijai K; Moriue S; Yokoya M; Chanvorachote P
BMC Complement Med Ther; 2023 Jun; 23(1):183. PubMed ID: 37270520
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
[TBL] [Abstract][Full Text] [Related]
10. Artocarpin Targets Focal Adhesion Kinase-Dependent Epithelial to Mesenchymal Transition and Suppresses Migratory-Associated Integrins in Lung Cancer Cells.
Nonpanya N; Sanookpan K; Sriratanasak N; Vinayanuwattikun C; Wichadakul D; Sritularak B; Chanvorachote P
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33920031
[TBL] [Abstract][Full Text] [Related]
11. Ti
Petpiroon N; Bhummaphan N; Soonnarong R; Chantarawong W; Maluangnont T; Pongrakhananon V; Chanvorachote P
Mol Pharmacol; 2019 Apr; 95(4):418-432. PubMed ID: 30737252
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties.
Alamdar N; Farivar S; Baghaei K; Hamidieh AA; Soltaninejad H; Aghdaei HA; Zali M; Saltanatpour Z
Curr Stem Cell Res Ther; 2024 Jan; ():. PubMed ID: 38303523
[TBL] [Abstract][Full Text] [Related]
13. Ascofuranone inhibits epidermal growth factor-induced cell migration by blocking epithelial-mesenchymal transition in lung cancer cells.
Kim HW; Jeong YJ; Hwang SK; Park YY; Choi YH; Kim CH; Magae J; Chang YC
Eur J Pharmacol; 2020 Aug; 880():173199. PubMed ID: 32439259
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
[TBL] [Abstract][Full Text] [Related]
16. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT.
Guefack MF; Talukdar D; Mukherjee R; Guha S; Mitra D; Saha D; Das G; Damen F; Kuete V; Murmu N
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117093. PubMed ID: 37634746
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
Han M; Liu M; Wang Y; Chen X; Xu J; Sun Y; Zhao L; Qu H; Fan Y; Wu C
PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
20. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
